Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19, Sars-Cov-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04420260
What this trial is testing

Primary Prevention of Infection by COVID-19 in Workers

Who this might be right for
COVID
Unidad de Investigación Genética Molecular 152
Not applicableUnknownNCT04425759
What this trial is testing

Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)

Who this might be right for
Covid19Corona Virus InfectionSARS-CoV 2+1 more
Hospital de Mataró 2,400
Not applicableStudy completedNCT05074680
What this trial is testing

COVID-19 Antibody Responses In Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Insel Gruppe AG, University Hospital Bern 5
Not applicableStudy completedNCT04828668
What this trial is testing

Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.

Who this might be right for
Covid 19
Endourage, LLC 32
Not applicableStudy completedNCT05910879
What this trial is testing

RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)

Who this might be right for
Health BehaviorHealth Care UtilizationVaccine Hesitancy
University of Oregon 625
Not applicableUnknownNCT04897646
What this trial is testing

The TELEAP1 CPAP-telemonitoring Study

Who this might be right for
Obstructive Sleep Apnea
University Hospital, Montpellier 300
Large-scale testing (Phase 3)UnknownNCT04802382
What this trial is testing

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Who this might be right for
Corona Virus InfectionCovid19SARS-CoV Infection
MGC Pharmaceuticals d.o.o 252
Not applicableUnknownNCT04407923
What this trial is testing

Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment

Who this might be right for
Juvenile Idiopathic ArthritisCOVID 19Treatment
University Hospital, Brest 150
Not applicableStudy completedNCT04365959
What this trial is testing

The Prone Position in Covid-19 Affected Patients

Who this might be right for
Sars-CoV2
University of Milano Bicocca 56
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT05975060
What this trial is testing

Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

Who this might be right for
COVID-19
Novavax 660
Not applicableUnknownNCT04739020
What this trial is testing

Respiratory Aerosols in Patients With COVID-19 and Healthy Controls

Who this might be right for
SARS-CoV-2 InfectionCovid19
Johann Wolfgang Goethe University Hospital 525
Not applicableUnknownNCT04348227
What this trial is testing

How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?

Who this might be right for
Ventilator Associated Pneumonia
Hôpital Universitaire Fattouma Bourguiba 120
Early research (Phase 1)Study completedNCT05181683
What this trial is testing

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Large-scale testing (Phase 3)Study completedNCT04435379
What this trial is testing

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic

Who this might be right for
Infection, Respiratory Tract
Serum Life Science Europe GmbH 2,038
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Not applicableStudy completedNCT06917261
What this trial is testing

Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample

Who this might be right for
SARS-CoV-2 Infection
University Hospital, Grenoble 400
Not applicableStudy completedNCT05178173
What this trial is testing

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)

Who this might be right for
COVID-19Coronavirus InfectionSARS CoV 2 Infection
University of North Carolina, Chapel Hill 230
Testing effectiveness (Phase 2)Study completedNCT06437223
What this trial is testing

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Who this might be right for
Long COVID
Inflammx Therapeutics Inc 16
Next Page